Elisabeth Engelsberger | Project Leader - Preclinical Development, Bioconjugates
Lonza

​​​​​​​Elisabeth is a Project Leader in Preclinical Development Bioconjugates at Lonza in Visp, Switzerland. She is responsible for leading preclinical bioconjugation projects, driving innovation from concept to candidate selection. She studied chemistry in Germany and the UK before pursuing her PhD at ETH Zürich, where she specialized in the interface between organic chemistry, peptide chemistry, and chemical biology.